Exonuclease deficient polymerases

US10947516B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10947516-B2
Application numberUS-201916280890-A
CountryUS
Kind codeB2
Filing dateFeb 20, 2019
Priority dateFeb 29, 2016
Publication dateMar 16, 2021
Grant dateMar 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are polymerase variants that are exonuclease deficient. Some variants retain the strand displacement capability comparable to the wild-type or parental polymerase. Some variants have a strand displacement capability that is improved relative to the wild-type or parental polymerase. The variants may have an extension rate that is greater than the wild-type or parental polymerase. The variants may have a waiting time that is less than the wild-type or parental polymerase.

First claim

Opening claim text (preview).

What is claimed is: 1. A modified DNA polymerase, derived from a parental DNA polymerase polypeptide having a DNA polymerase activity comprising an amino acid sequence having at least 80% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 1, comprising a substitution at a position corresponding to a position selected from the group consisting of T45, H123, L125, W127, D128, V179, S211, Y212, I215, T216, E219, Q221, E239, D241, Y259, Q260, A292, S293, and S294 of SEQ ID NO: 2, wherein the modified polymerase is exonuclease deficient. 2. The modified DNA polymerase according to claim 1 , wherein said modified polymerase retains a strand displacement capability. 3. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution selected from L125K, D128H, V179Y, V179R, S211F, Y212K, I215L, T216K, Q221R, Y259G/K/Q, A292K, S293G, and S294T. 4. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution corresponding to L125K. 5. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution corresponding to D128H. 6. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution corresponding to V179Y or V179R. 7. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution selected from the group consisting of S211F, Y212K, I215L, T216K, and Q221R. 8. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution corresponding to Y259G. 9. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution corresponding to Y259K. 10. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution corresponding to Y259Q. 11. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a substitution selected from the group consisting of A292K, S293G, and S294T. 12. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has at least 90%, 95%, 96%, 97%, 98% or 99% sequence identity to SEQ ID NO: 1. 13. The modified DNA polymerase according to claim 1 , wherein said modified polymerase comprises a set of substitutions selected from the group consisting of: a. T529M+S366A+A547F+Y259G/K/Q, b. T529M+S366A+A547F+D128H, c. T529M+S366A+A547F+Y212G, and d. T529M+S366A+A547F+Y212K. 14. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has an extension rate that is greater than the parental polymerase. 15. The modified DNA polymerase of claim 14 , wherein the extension rate is at least 1.5 times greater than the parental polymerase. 16. The modified DNA polymerase according to claim 1 , wherein said modified polymerase has a median waiting time that is less than the wild-type or parental polymerase. 17. The modified DNA polymerase according to claim 16 , wherein said modified polymerase has a median waiting time that is less than the waiting time of the polymerase according to SEQ ID NO: 11. 18. The modified DNA polymerase according to claim 16 , wherein said modified polymerase has a median waiting time that is less than 3 seconds. 19. An exonuclease-deficient DNA polymerase having a strand displacement activity, wherein said exonuclease-deficient DNA polymerase comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 1 and comprises a substitution at a position corresponding to a position selected from the group consisting of T45, H123, L125, W127, D128, V179, S211, Y212, I215, T216, E219, Q221, E239, D241, Y259, Q260, A292, S293, and S294 of SEQ ID NO: 2. 20. The exonuclease-deficient DNA polymerase of claim 19 , wherein said exonuclease-deficient DNA polymerase has a shorter wait time than a DNA polymerase according to SEQ ID NO: 1.

Assignees

Inventors

Classifications

  • DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • C12N9/1252Primary

    DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10947516B2 cover?
Described herein are polymerase variants that are exonuclease deficient. Some variants retain the strand displacement capability comparable to the wild-type or parental polymerase. Some variants have a strand displacement capability that is improved relative to the wild-type or parental polymerase. The variants may have an extension rate that is greater than the wild-type or parental polymerase…
Who is the assignee on this patent?
Roche Sequencing Solutions Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/1252. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).